Avantor Stock Price, News & Analysis

Avantor, Inc. (NYSE: AVTR) reported preliminary unaudited revenues for Q3 2020, with total revenues of $1.60 billion, reflecting a 6.7% increase and 5.4% organic growth. The results indicate strong performance, particularly in the biopharma and healthcare markets. The company will release full financial results on October 28, 2020. It is important to note that these figures are preliminary and unaudited, pending final review.

Avantor, a leading global provider in life sciences and advanced technologies, has announced a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock. This equates to a yield of 1.560% and will be payable on November 15, 2020, to shareholders recorded by November 1, 2020. This decision reflects Avantor's commitment to providing returns to its stakeholders while maintaining a strong position within the industry.

Avantor (NYSE: AVTR) announced that its General Counsel, Justin Miller, has been honored as a 'Legend In Law' by The Burton Awards Program, recognizing his outstanding legal achievements. He is one of 13 honorees this year, acknowledged for his exceptional reputation and contributions to the legal profession. Miller's career highlights include a significant federal case win at age 26 and leading Avantor's initial public offering in May 2019. The awards celebrate leaders who tackle complex legal challenges on a national and global scale.

Avantor, a global provider of mission-critical products and services, is set to release its third quarter 2020 financial results on October 28, 2020, after market close. A conference call will take place at 5:00 p.m. EDT the same day to discuss the results. Investors can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally, using access code 3557106. The earnings press release and related slides will be available on their website. A replay will be accessible until November 12, 2020.

Avantor has appointed Frederic Vanderhaegen as Executive Vice President for the Americas and Europe, effective immediately. He expands his role to include the Americas, enhancing the company's focus on customer research and development. This strategic move aims to improve customer service and innovation in the company’s offerings. Vanderhaegen, who joined Avantor in 2018, brings extensive leadership experience in the life sciences sector.

Avantor, a global leader in mission-critical products and services, will participate in the Morgan Stanley Virtual Healthcare Conference on September 16, 2020. CEO Michael Stubblefield is scheduled to present at 8:45 a.m. ET. Investors can access a live webcast through Avantor's investor relations page, which will remain available for replay until September 30, 2020. Avantor serves over 225,000 customers across various sectors, including biopharma and healthcare.

Avantor, a leading global provider of critical products and services, will participate in the 2020 Wells Fargo Virtual Healthcare Conference on September 10, 2020. President and CEO Michael Stubblefield will represent the company at approximately 10:00 a.m. Eastern Time. A live webcast will be available through Avantor's investor relations section and can be replayed until September 24, 2020. Avantor serves over 225,000 customer locations globally, supporting the biopharma, healthcare, education, and technology sectors.

Avantor, Inc. (NYSE: AVTR) announced the pricing of an upsized secondary offering by certain stockholders, including New Mountain Capital. A total of 55,555,555 shares of common stock will be sold for gross proceeds of approximately $1.1 billion. This is an increase from the originally proposed 38,500,000 shares. The offering will close on August 21, 2020, pending customary conditions. The underwriters have an option to purchase an additional 8,333,333 shares. The company itself is not selling any shares and will not receive any proceeds from this offering.

Avantor, Inc. (NYSE: AVTR) announced an underwritten secondary offering of 38,500,000 shares of common stock by certain stockholders, including an affiliate of New Mountain Capital. The underwriters, Goldman Sachs & Co. LLC and J.P. Morgan, may acquire an additional 5,775,000 shares. The proceeds will go entirely to the selling stockholders, as no shares are being sold by the company itself. A registration statement with the SEC has been filed and is effective. The offering will be conducted via a prospectus supplement.